syngo.CT CaScoring vs ClearRead CT
AI Verdict
Choose syngo.CT CaScoring if…
Choose syngo.CT CaScoring if your primary need is a highly specialized and integrated solution for detailed coronary artery calcification assessment within a Siemens CT imaging environment. This tool excels at providing precise quantification, visualization, and standardized scoring (e.g., Agatston, MESA comparison) specifically for cardiovascular risk stratification.
View syngo.CT CaScoring →Choose ClearRead CT if…
Choose ClearRead CT if you require a comprehensive AI suite for broader cardiothoracic health, encompassing both pulmonary nodule detection and coronary artery calcification analysis from ungated CTs. This solution is ideal for streamlining radiology workflows, improving diagnostic accuracy across multiple findings, and offers flexible, vendor-neutral deployment options.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | syngo.CT CaScoring | ClearRead CT |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Integrated with Siemens CT scanner systems; operates as a post-processing application on the multi-user syngo.via client/server platform. | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ClearRead CTClearRead CT offers vendor-neutral PACS integration and flexible deployment options (on-premise and cloud), suggesting broader compatibility and ease of integration into existing radiology environments. It explicitly highlights reduced reading times and streamlined workflows, directly indicating enhanced usability. In contrast, syngo.CT CaScoring is integrated within the Siemens ecosystem, which, while efficient for Siemens users, limits its universal applicability.
Clinical Value
ClearRead CTClearRead CT provides a broader clinical scope by offering both pulmonary nodule detection and coronary artery calcification analysis, with claims of improved detection accuracy (29% reduction in missed actionable nodules) and reduced reading times (up to 36%). Its patented vessel suppression technology further enhances diagnostic clarity. While syngo.CT CaScoring offers comprehensive CAC analysis, its clinical focus is narrower.
Pricing & Value
syngo.CT CaScoringsyngo.CT CaScoring, despite its 'contact for pricing' model, provides historical pricing information from a 2018 NY.Gov document, indicating a one-time license purchase and a ballpark figure. This offers a degree of transparency regarding its potential cost structure. ClearRead CT, on the other hand, offers no public or historical pricing details, making it less transparent in this dimension.
Enterprise Readiness
ClearRead CTClearRead CT demonstrates superior enterprise readiness through its flexible deployment options (on-premise and cloud), vendor-neutral PACS integration, and explicit mention of operating with institutions like the VA. Its ISO27001 certification further underscores its commitment to robust security and data management, making it highly adaptable to diverse IT infrastructures. While syngo.CT CaScoring is from a major vendor, its integration is tied to the Siemens ecosystem.
Innovation
ClearRead CTClearRead CT's patented vessel suppression technology (Clear Visual Intelligence) represents a significant innovation in image processing, actively improving clarity for both nodule detection and CAC analysis. Its explicit claims of improved detection accuracy and automated nodule tracking further highlight its innovative edge in enhancing clinical utility. syngo.CT CaScoring focuses on advanced quantification and visualization but lacks a comparable unique technological differentiator.
Support & Docs
ClearRead CTRiverain Technologies provides a more detailed and accessible support infrastructure, including direct contact options, a support ticket system, and a comprehensive online resource center with FAQs, manuals, and technical specifications. While Siemens Healthineers offers support and documentation, Riverain's public-facing resources appear more explicitly structured and user-friendly for immediate assistance and self-service.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | syngo.CT CaScoring | ClearRead CT |
|---|---|---|
| Name | syngo.CT CaScoring | ClearRead CT |
| Company | Siemens Medical Solutions USA | RIVERAIN TECHNOLOGIES |
| Tagline | AI-powered quantification and visualization of coronary calcifications | AI-Driven Clarity for Faster & More Confident Nodule Detection |
| Main Application Area | AI-powered image analysis software for quick quantification and accurate visualization of calcified coronary lesions from CT scans, aiding in cardiovascular risk assessment and documentation. | FDA-cleared AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. |
| Primary AI Categories | Cardiology AI | Cardiology AI, Oncology AI, Radiology & Imaging AI |
| Specific CAC Scoring Capabilities | Quick quantification and accurate visualization of calcified coronary lesions; Calculation of Agatston Score, volume, and calcium mass; Assessment of plaque burden in total and per coronary artery (RCA, LM, LAD, CX); Automatic highlighting of coronary calcifications; User-modifiable threshold for score calculation (default 130 HU); Comparison of patient score to healthy reference groups (e.g., MESA study); Calculation of 'Coronary Age'. | Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs) |
| Pulmonary Nodule Detection Capabilities | Not specified | Pulmonary Nodule Detection (solid, part-solid, ground glass); Nodule Characterization and Measurement (volume, diameter, location, type, depth); Automated Nodule Tracking and Comparison to Prior Exams; Improved Detection Accuracy (29% reduction in missed actionable nodules). |
Videos
Demos, reviews, and walkthroughs featuring syngo.CT CaScoring and ClearRead CT.